16 December 2009
ALLOCATE SOFTWARE PLC
("Allocate" or "the Company")
Completion of the Acquisition of Time Care AB
The Board of Allocate (the "Board") is pleased to announce that, further to its announcement of 27 November
2009, the Company has completed the acquisition of Time Care AB ("Time Care"), a Swedish-based provider of
workforce management software, with a strong focus on the healthcare market, for a Net Consideration of SEK 100
million (approximately £8.7 million)1.
The Company successfully raised approximately £8.3 million (approximately £8.0 million net of expenses) through
a cash placing of 15,100,000 new ordinary shares ("New Shares") at 55.0 pence per New Share to help fund the
Acquisition (the "Placing"), with the balance being satisfied from the Company's existing cash resources.
As at Completion, all Vendors had signed the Acquisition Agreement. Consequently, Allocate has now acquired
the entire issued and to be issued share capital of Time Care.
The Acquisition is currently expected by the Directors to be significantly earnings enhancing in the first full
financial year of ownership by Allocate.
Terms defined in the Circular sent to Shareholders on 27 November 2009 have the same meanings in this
announcement.
Enquiries:
Allocate Software plc Tel: +44 (0) 20 7355 5555
Ian Bowles - Chief Executive Officer
Simon Thorne - Chief Financial Officer
Numis Securities Limited
Nominated adviser - Michael Meade / Brent Nabbs Tel: +44 (0) 20 7260 1000
Corporate Broking - James Black
Strata Partners (Financial Adviser) Tel: +44 (0) 20 7730 1200
Edward Roskill
Hansard Group Tel: +44 (0) 20 7245 1100
Justine James
Kirsty Corcoran
Strata Partners, which is authorised and regulated in the United Kingdom by the Financial Services Authority,
is Allocate's exclusive financial adviser for the Acquisition. Strata Partners is acting exclusively for the
Company and will not be responsible to any other person for providing the protections afforded to customers of
each of them nor for providing advice in relation to the contents of this announcement or any other matter
referred to herein.
Numis Securities Limited, which is authorised and regulated in the United Kingdom by the Financial Services
Authority and is a member of the London Stock Exchange, is Allocate's nominated adviser and broker for the
purposes of the AIM Rules. Numis Securities Limited is acting exclusively for the Company and will not be
responsible to any other person for providing the protections afforded to customers of each of them nor for
providing advice in relation to the contents of this announcement or any other matter referred to herein.
The distribution of this announcement in jurisdictions other than the UK may be restricted by law and therefore
persons into whose possession this document comes should inform themselves about and observe any of those
restrictions. Any failure to comply with any of those restrictions may constitute a violation of the
securities laws of any such jurisdiction.
_______________________________
1 Exchange rate of £1 = 11.50 SEK as at 26 November 2009, being the last business day prior to the announcement
of the Acquisition
Allocate Software plc
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.